Summary
The Defense Health Agency (DHA) issued a sole-source justification (HT940226F0008) requesting independent technical, regulatory, and economic due diligence and feasibility assessments to evaluate proposed domestic pharmaceutical manufacturing solutions and strengthen military medical supply chain resilience. The notice was published on SAM.gov on 2026-07-16 and designates the effort as urgent under FAR 16.507-6(b)(1); work is to be performed in Arlington, VA under a task-order structure. The SAM.gov posting shows an inactive (archive) date of 2026-08-15 and does not list a primary solicitation PDF or a response deadline on the notice.